Publication | Open Access
Activities of New Antimicrobial Agents (Trovafloxacin, Moxifloxacin, Sanfetrinem, and Quinupristin-Dalfopristin) against <i>Bacteroides fragilis</i> Group: Comparison with the Activities of 14 Other Agents
33
Citations
16
References
1999
Year
Antimicrobial ActivitiesAntimicrobial ChemotherapyBacterial PathogensDrug ResistanceAntimicrobial TherapyInfection ControlNew Antimicrobial AgentsAntimicrobial ResistanceHealth SciencesAntimicrobial Drug DiscoveryOther AgentsAntibacterial AgentAntimicrobial PharmacokineticsAntimicrobial CompoundPharmacologyClinical MicrobiologyLowest MicsAntimicrobial SusceptibilityAntibioticsMicrobiologyAntimicrobial AgentsAntimicrobial PharmacodynamicsMedicineImipenem-resistant Strains
The antimicrobial activities of trovafloxacin, moxifloxacin, sanfetrinem, quinupristin-dalfopristin, and 14 other antimicrobial agents against 218 Bacteroides fragilis group strains were determined. A group of 10 imipenem-resistant strains were also tested. Imipenem, meropenem, and sanfetrinem had the lowest MICs of all of the beta-lactams. Quinupristin-dalfopristin inhibited all of the strains at 2 microg/ml. Overall, the MICs of trovafloxacin and moxifloxacin for 90% of the strains tested were 1 and 2 microg/ml, respectively.
| Year | Citations | |
|---|---|---|
Page 1
Page 1